Jing Huang

22PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 30, 2025
Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial.

Wang Qu, Jing Gao, Bo Zhang

|Oct 02, 2025
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials.

Jian Li, Ting Deng, Yanhong Gu

|May 12, 2025
Circulating Tumor DNA Dynamic Changes in Esophageal Squamous Cell Carcinoma Receiving Immunochemotherapy.

Yijia Guo, Wang Qu, Yun Liu

|Jan 17, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial.

Zhichao Tan, Yan Wu, Zhengfu Fan

|Oct 24, 2024
HLX07 alone or combined with serplulimab, cisplatin and 5-fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study.

Yun Liu, Yanfeng Wang, Yanrong Zhu

|May 21, 2024
The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysis.

Jing Gao, Yan Song, Xiaoge Kou

Pageof 4

Frequent Collaborators

3 joint publications

Bo Zhang

2 joint publications

Lin Wang

2 joint publications

Rui-Hua Xu

2 joint publications

Dao Xin